相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis
Maxwell T. Chirehwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis
Abdullah Alsultan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pattern Recognition in Pharmacokinetic Data Analysis
Johan Gabrielsson et al.
AAPS JOURNAL (2016)
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction
Maxwell T. Chirehwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies
Igor Kramnik et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration
Kelly Stinson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
TB Alliance regimen development for multidrug-resistant tuberculosis
S. Murray et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Prediction of Drug Penetration in Tuberculosis Lesions
Jansy P. Sarathy et al.
ACS INFECTIOUS DISEASES (2016)
Population Pharmacokinetics of Bedaquiline and Metabolite M2 in Patients With Drug-Resistant Tuberculosis: The Effect of Time-Varying Weight and Albumin
E. M. Svensson et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
Andreas H. Diacon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts et al.
IMMUNOLOGICAL REVIEWS (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics
Anja Wilmes et al.
TOXICOLOGY IN VITRO (2015)
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
Paolo Denti et al.
PLOS ONE (2015)
Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and Bioavailability
Radojka M. Savic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin
Kelly E. Dooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug
Sarah C. McLeay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
Suresh B. Lakshminarayana et al.
PLOS ONE (2014)
Evaluation of Pharmacokinetic Interaction between PA-824 and Midazolam in Healthy Adult Subjects
Helen Winter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effect of a High-Calorie, High-Fat Meal on the Bioavailability and Pharmacokinetics of PA-824 in Healthy Adult Subjects
Helen Winter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose Rifapentine
Simbarashe P. Zvada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
Zahoor Ahmad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The TB Alliance: overcoming challenges to chart the future course of TB drug development
Ann Ginsberg
FUTURE MEDICINAL CHEMISTRY (2011)
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
Jan-Willem C. Alffenaar et al.
THERAPEUTIC DRUG MONITORING (2010)
Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
Ann M. Ginsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects
Ann M. Ginsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis
Bryan McGee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models
Frederic Y. Bois
BIOINFORMATICS (2009)
Sex Differences in Pharmacokinetics and Pharmacodynamics
Offie P. Soldin et al.
CLINICAL PHARMACOKINETICS (2009)
Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach
Weihsueh A. Chiu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Comprehensive treatment of extensively drug-resistant tuberculosis
Carole D. Mitnick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
Radojka M. Savic et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics
FY Bois
ENVIRONMENTAL HEALTH PERSPECTIVES (2000)
分享论文
